Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06438705
Status:
RECRUITING
Last Update Posted:
2024-06-03
First Post:
2024-05-07
Brief Title:
99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors
Sponsor:
Nanjing First Hospital Nanjing Medical University
Organization:
Nanjing First Hospital Nanjing Medical University
Study Overview
Official Title:
Clinical Application of a Novel 99mTc Labeled Fibroblast Activating Protein FAP Targeted Molecular Probe in Early Diagnosis of Tumors
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
At present radiopharmaceuticals targeting FAP have been developed for the diagnosis and treatment of various tumors Considering the problems of fast tumor tissue clearance and short retention time in small molecule FAP inhibitors based on quinoline rings this project optimized their ligands and developed a new FAP targeted technetium labeled molecular imaging probe for SPECTCT imaging research to evaluate its safety in clinical application and its effectiveness in tumor diagnosis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None